Interactions between Retroviruses and the Host Cell Genome
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our findings demonstrate that IVT mRNA provides a transient, non-integrating platform, which mitigates theoretical safety concerns by avoiding risks of insertional mutagenesis and irreversible genomic alterations associated with viral vectors or CRISPR-Cas9 systems,11,12,13,14,18 while enabling sophisticated multiplexing strategies and potentially enhancing functional efficacy.28,29,30,31,32,45,65”
From Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation (2026) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961 · cited 2×
“Enhancers are the major source of BRD4-dependent transcriptional activation,(87) and genes under the control of super-enhancers are particularly sensitive to BET inhibition.(88)”
BackgroundHIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305 · cited 2×
“5 kb upstream or downstream of the +1 position of target genes.(4,15,16,65) Thus, gene promoters were considered for some time as the major target of MLV integration.”
BackgroundHIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704 · cited 2×
“In vitro assays with purified INs have revealed that LEDGF/p75 significantly stimulates the strand transfer activity of lentiviral but no other retroviral INs.(27,29,39,47) Studies using LEDGF/p75 knockout cells revealed 5- to 80-fold defects in HIV-1 infectivity, associated with 2- to 12-fold reduction in integration.”
BackgroundA role for LEDGF/p75 in targeting HIV DNA integration
Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R., & Bushman, F. (2005) · Nature Medicine · doi:10.1038/nm1329 · Cited by 658
Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C. C., Ranzani, M., Benedicenti, F., Sergi, L. S., Ambrosi, A., Ponzoni, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37630 · Cited by 571
An essential role for LEDGF/p75 in HIV integration
Llano, M., Saenz, D. T., Meehan, A., Wongthida, P., Peretz, M., Walker, W. H., Teo, W., & Poeschla, E. M. (2006) · Science · doi:10.1126/science.1132319 · Cited by 537
LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells
Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., & Engelborghs, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303594200 · Cited by 493 · cited 1×
“LEDGF/p75 belongs to the hepatoma-derived growth factor-related protein (HRP) family, which comprises five additional members—HDGF, HRP1-3, and LEDGF/p52, an alternatively spliced, smaller isoform of LEDGF— that, except for HRP2, lack the domains necessary to HIV-1 IN interaction.(37) LEDGF/p75 is characterized by a c…”
BackgroundShun, M.-C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., Cherepanov, P., & Engelman, A. (2007) · Genes & Development · doi:10.1101/gad.1565107 · Cited by 467 · cited 3×
“The conserved C-terminal extra-terminal (ET) and SEED, Ser/Glu/Asp-rich, domains directly bind several cellular proteins including transcription factors, chromatin-modifying proteins, and histone modification enzymes.89 BET proteins directly bind acetylated histone tails, so their association with strong enhancers is…”
BackgroundWang, G. P., Ciuffi, A., Leipzig, J., Berry, C. C., & Bushman, F. D. (2007) · Genome Research · doi:10.1101/gr.6286907 · Cited by 457
Retroviral DNA integration: viral and cellular determinants of target-site selection
Lewinski, M. K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020060 · Cited by 364 · cited 2×
“packaged with MLV Gag proteins had suggested that other components of the PIC, in particular the p12 Gag protein, may have a role in MLV target site selection.(71) The MLV p12 is a constituent of the PIC, but its function in the complex remains ill-defined.”
Llano, M., Vanegas, M., Fregoso, O., Saenz, D., Chung, S., Peretz, M., & Poeschla, E. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9524-9537.2004 · Cited by 305 · cited 1×
“Interestingly, LEDGF/p75 fails to interact with INs from other retroviral genera.(28,45,46) In vitro assays with purified INs have revealed that LEDGF/p75 significantly stimulates the strand transfer activity of lentiviral but no other retroviral INs.”
BackgroundCherepanov, P., Devroe, E., Silver, P. A., & Engelman, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406307200 · Cited by 287 · cited 5×
“The role of LEDGF/p75 in mediating HIV infectivity has been deeply investigated because of its tight interaction with the viral IN and its role in stimulating the IN catalytic activity in vitro.27–29 LEDGF/p75 knockdown significantly reduces HIV-1 infectivity, showing the functional role of this protein as the major c…”
BackgroundInfluentialPryciak, P. M., & Varmus, H. E. (1992) · Cell · doi:10.1016/0092-8674(92)90289-o · Cited by 273
Biasco, L., Pellin, D., Scala, S., Dionisio, F., Basso-Ricci, L., Leonardelli, L., Scaramuzza, S., Baricordi, C., Ferrua, F., Cicalese, M. P., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.04.016 · Cited by 243
Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting
Marshall, H. M., Ronen, K., Berry, C., Llano, M., Sutherland, H., Saenz, D., Bickmore, W., Poeschla, E., & Bushman, F. D. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001340 · Cited by 241 · cited 3×
“The conserved C-terminal extra-terminal (ET) and SEED, Ser/Glu/Asp-rich, domains directly bind several cellular proteins including transcription factors, chromatin-modifying proteins, and histone modification enzymes.89 BET proteins directly bind acetylated histone tails, so their association with strong enhancers is…”
BackgroundPruss, D., Bushman, F. D., & Wolffe, A. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.5913 · Cited by 236
The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication
Engelman, A., & Cherepanov, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000046 · Cited by 231
HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2
Ocwieja, K. E., Brady, T. L., Ronen, K., Huegel, A., Roth, S. L., Schaller, T., James, L. C., Towers, G. J., Young, J. A. T., Chanda, S. K., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001313 · Cited by 212
The Interaction of LEDGF/p75 with Integrase Is Lentivirus-specific and Promotes DNA Binding
Busschots, K., Vercammen, J., Emiliani, S., Benarous, R., Engelborghs, Y., Christ, F., & Debyser, Z. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411681200 · Cited by 208 · cited 1×
“Interestingly, LEDGF/p75 fails to interact with INs from other retroviral genera.(28,45,46) In vitro assays with purified INs have revealed that LEDGF/p75 significantly stimulates the strand transfer activity of lentiviral but no other retroviral INs.”
BackgroundStructural basis for high-affinity binding of LEDGF PWWP to mononucleosomes
Eidahl, J. O., Crowe, B. L., North, J. A., McKee, C. J., Shkriabai, N., Feng, L., Plumb, M., Graham, R. L., Gorelick, R. J., Hess, S., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt074 · Cited by 207 · cited 4×
“NMR structures of the LEDGF/p75 PWWP domain revealed two distinct functional interfaces: a hydrophobic pocket that interacts with the H3K36me3 histone tail and an adjacent basic interface that non-specifically engages DNA.(41,42) Interestingly, the LEDGF/ p75 PWWP domain exhibits low binding affinity for either an H3K…”
BackgroundInfluentialLlano, M., Vanegas, M., Hutchins, N., Thompson, D., Delgado, S., & Poeschla, E. M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.04.073 · Cited by 199
BET proteins promote efficient murine leukemia virus integration at transcription start sites
Sharma, A., Larue, R. C., Plumb, M. R., Malani, N., Male, F., Slaughter, A., Kessl, J. J., Shkriabai, N., Coward, E., Aiyer, S. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307157110 · Cited by 193 · cited 5×
“8 March 2 Binding of BRD2, BRD3, and BRD4 to theMLV IN is mediated by the ET domain.(86,94,95) Solution NMR and protein interaction studies showed that the unstructured C-terminal polypeptide (TP) domain of the MLV IN directly binds the BET ET domain and acquires a secondary structure upon complex formation.”
BackgroundMethodInfluentialTurlure, F. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl052 · Cited by 181 · cited 3×
“In vitro assays with purified INs have revealed that LEDGF/p75 significantly stimulates the strand transfer activity of lentiviral but no other retroviral INs.(27,29,39,47) Studies using LEDGF/p75 knockout cells revealed 5- to 80-fold defects in HIV-1 infectivity, associated with 2- to 12-fold reduction in integration.”
BackgroundDe Rijck, J., de Kogel, C., Demeulemeester, J., Vets, S., El Ashkar, S., Malani, N., Bushman, F. D., Landuyt, B., Husson, S. J., Busschots, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.040 · Cited by 175
The influence of DNA and nucleosome structure on integration events directed by HIV integrase
Pruss, D., Reeves, R., Bushman, F. D., & Wolffe, A. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31494-1 · Cited by 173
Cherepanov, P. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl885 · Cited by 173
Holman, A. G., & Coffin, J. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501646102 · Cited by 164
Gupta, S. S., Maetzig, T., Maertens, G. N., Sharif, A., Rothe, M., Weidner-Glunde, M., Galla, M., Schambach, A., Cherepanov, P., & Schulz, T. F. (2013) · Journal of Virology · doi:10.1128/jvi.01942-13 · Cited by 139
Koh, Y., Wu, X., Ferris, A. L., Matreyek, K. A., Smith, S. J., Lee, K., KewalRamani, V. N., Hughes, S. H., & Engelman, A. (2013) · Journal of Virology · doi:10.1128/jvi.01148-12 · Cited by 122
Enhancers Are Major Targets for Murine Leukemia Virus Vector Integration
De Ravin, S. S., Su, L., Theobald, N., Choi, U., Macpherson, J. L., Poidinger, M., Symonds, G., Pond, S. M., Ferris, A. L., Hughes, S. H., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00011-14 · Cited by 103 · cited 2×
“These studies confirmed the HIV-1 preference for transcribed gene bodies, and revealed a negative correlation between integration frequency and TSSs and other typical feature of gene promoters, such as CpG islands, G/C-rich sequences, DNase I hypersensitive sites, and clusters of transcription factor binding sites (TF…”
BackgroundSequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration
Stevens, S. W., & Griffith, J. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6459-6462.1996 · Cited by 96
Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins
LeRoy, G., Chepelev, I., DiMaggio, P. A., Blanco, M. A., Zee, B. M., Zhao, K., & Garcia, B. A. (2012) · Genome Biology · doi:10.1186/gb-2012-13-8-r68 · Cited by 84
Shun, M.-C., Botbol, Y., Li, X., Di Nunzio, F., Daigle, J. E., Yan, N., Lieberman, J., Lavigne, M., & Engelman, A. (2008) · Journal of Virology · doi:10.1128/jvi.01561-08 · Cited by 78
p12 Tethers the Murine Leukemia Virus Pre-integration Complex to Mitotic Chromosomes
Elis, E., Ehrlich, M., Prizan-Ravid, A., Laham-Karam, N., & Bacharach, E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003103 · Cited by 76 · cited 1×
“The insertion of a heterologous chromatin binding module into p12 restores PIC attachment to chromosomes, confirming the role of p12 as a tethering factor to mitotic chromosomes.(97) Later studies, however, demonstrated that mutations altering the p12 interaction with chromatin have no detectable effects on the MLV in…”
BackgroundChromatin Tethering of Incoming Foamy Virus by the Structural Gag Protein
Tobaly‐Tapiero, J., Bittoun, P., Lehmann‐Che, J., Delelis, O., Giron, M., De Thé, H., & Saïb, A. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00792.x · Cited by 74 · cited 1×
“The FV Gag contains a C-terminal chromatin-binding site (CBS) that allows the interaction of PICs with the core histones H2A and H2B on host chromatin.(111) FV PICs can be retargeted to satellite elements and H3K9me3-positive heterochromatin by modifying the Gag CBS and the IN proteins,(112) indicating that a Gag/IN-b…”
BackgroundAiyer, S., Swapna, G. V. T., Malani, N., Aramini, J. M., Schneider, W. M., Plumb, M. R., Ghanem, M., Larue, R. C., Sharma, A., Studamire, B., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku175 · Cited by 72 · cited 2×
“Solution NMR and protein interaction studies showed that the unstructured C-terminal polypeptide (TP) domain of the MLV IN directly binds the BET ET domain and acquires a secondary structure upon complex formation.(96) Deletion of the TP domain does not disrupt the catalytic properties of IN but widely alters the MLV…”
BackgroundDemeulemeester, J., De Rijck, J., Gijsbers, R., & Debyser, Z. (2015) · BioEssays · doi:10.1002/bies.201500051 · Cited by 71
Gammaretroviral Integration into Nucleosomal Target DNA In Vivo
Roth, S. L., Malani, N., & Bushman, F. D. (2011) · Journal of Virology · doi:10.1128/jvi.00635-11 · Cited by 69
Schneider, W. M., Brzezinski, J. D., Aiyer, S., Malani, N., Gyuricza, M., Bushman, F. D., & Roth, M. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221736110 · Cited by 49
Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes
Larue, R. C., Plumb, M. R., Crowe, B. L., Shkriabai, N., Sharma, A., DiFiore, J., Malani, N., Aiyer, S. S., Roth, M. J., Bushman, F. D., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku135 · Cited by 44
3D hotspots of recurrent retroviral insertions reveal long-range interactions with cancer genes
Babaei, S., Akhtar, W., de Jong, J., Reinders, M., & de Ridder, J. (2015) · Nature Communications · doi:10.1038/ncomms7381 · Cited by 37
Research works printed but not linked: 71
- Schmidt, 2001, Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples, Hum. Gene Ther., 12, 743, 10.1089/104303401750148649 · DOI · Paper page
- Derse, 2007, Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses, J. Virol., 81, 6731, 10.1128/JVI.02752-06 · DOI · Paper page
- Taganov, 2004, Integrase-specific enhancement and suppression of retroviral DNA integration by compacted chromatin structure in vitro, J. Virol., 78, 5848, 10.1128/JVI.78.11.5848-5855.2004 · DOI · Paper page
- Berry, 2006, Selection of target sites for mobile DNA integration in the human genome, PLoS Comput. Biol., 2, e157, 10.1371/journal.pcbi.0020157 · DOI · Paper page
- Carteau, 1998, Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target, J. Virol., 72, 4005, 10.1128/JVI.72.5.4005-4014.1998 · DOI · Paper page
- Wu, 2005, Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses, J. Virol., 79, 5211, 10.1128/JVI.79.8.5211-5214.2005 · DOI · Paper page
- Hematti, 2004, Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells, PLoS Biol., 2, e423, 10.1371/journal.pbio.0020423 · DOI · Paper page
- Mitchell, 2004, Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences, PLoS Biol., 2, E234, 10.1371/journal.pbio.0020234 · DOI · Paper page
- Cattoglio, 2010, High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors, Blood, 116, 5507, 10.1182/blood-2010-05-283523 · DOI · Paper page
- Wang, 2009, Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells, Mol. Ther., 17, 844, 10.1038/mt.2009.16 · DOI · Paper page
- Cattoglio, 2010, High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion, PLoS ONE, 5, e15688, 10.1371/journal.pone.0015688 · DOI
- Marini, 2015, Nuclear architecture dictates HIV-1 integration site selection, Nature, 521, 227, 10.1038/nature14226 · DOI · Paper page
- Mulder, 2002, Interaction of HIV-1 integrase with DNA repair protein hRad18, J. Biol. Chem., 277, 27489, 10.1074/jbc.M203061200 · DOI · Paper page
- Kalpana, 1994, Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5, Science, 266, 2002, 10.1126/science.7801128 · DOI · Paper page
- Violot, 2003, The human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1, J. Virol., 77, 12507, 10.1128/JVI.77.23.12507-12522.2003 · DOI · Paper page
- Li, 2000, Retroviral cDNA integration: stimulation by HMG I family proteins, J. Virol., 74, 10965, 10.1128/JVI.74.23.10965-10974.2000 · DOI · Paper page
- Emiliani, 2005, Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication, J. Biol. Chem., 280, 25517, 10.1074/jbc.M501378200 · DOI · Paper page
- Llano, 2004, Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase, J. Biol. Chem., 279, 55570, 10.1074/jbc.M408508200 · DOI · Paper page
- Maertens, 2006, Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin, J. Cell Sci., 119, 2563, 10.1242/jcs.02995 · DOI · Paper page
- Ge, 1998, Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation, EMBO J., 17, 6723, 10.1093/emboj/17.22.6723 · DOI · Paper page
- Bartholomeeusen, 2007, Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75, J. Mol. Biol., 372, 407, 10.1016/j.jmb.2007.06.090 · DOI
- Hughes, 2010, Transcriptional co-activator LEDGF interacts with Cdc7-activator of S-phase kinase (ASK) and stimulates its enzymatic activity, J. Biol. Chem., 285, 541, 10.1074/jbc.M109.036491 · DOI
- Bartholomeeusen, 2009, Lens epithelium-derived growth factor/p75 interacts with the transposase-derived DDE domain of PogZ, J. Biol. Chem., 284, 11467, 10.1074/jbc.M807781200 · DOI · Paper page
- Yokoyama, 2008, Menin critically links MLL proteins with LEDGF on cancer-associated target genes, Cancer Cell, 14, 36, 10.1016/j.ccr.2008.05.003 · DOI · Paper page
- Gijsbers, 2011, Role of the PWWP domain of lens epithelium-derived growth factor (LEDGF)/p75 cofactor in lentiviral integration targeting, J. Biol. Chem., 286, 41812, 10.1074/jbc.M111.255711 · DOI · Paper page
- van Nuland, 2013, Nucleosomal DNA binding drives the recognition of H3K36-methylated nucleosomes by the PSIP1-PWWP domain, Epigenetics Chromatin, 6, 12, 10.1186/1756-8935-6-12 · DOI · Paper page
- Schrijvers, 2012, LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs, PLoS Pathog., 8, e1002558, 10.1371/journal.ppat.1002558 · DOI · Paper page
- Fadel, 2014, TALEN knockout of the PSIP1 gene in human cells: analyses of HIV-1 replication and allosteric integrase inhibitor mechanism, J. Virol., 88, 9704, 10.1128/JVI.01397-14 · DOI · Paper page
- De Rijck, 2006, Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication, J. Virol., 80, 11498, 10.1128/JVI.00801-06 · DOI · Paper page
- Meehan, 2011, LEDGF dominant interference proteins demonstrate prenuclear exposure of HIV-1 integrase and synergize with LEDGF depletion to destroy viral infectivity, J. Virol., 85, 3570, 10.1128/JVI.01295-10 · DOI
- Ferris, 2010, Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration, Proc. Natl. Acad. Sci. USA, 107, 3135, 10.1073/pnas.0914142107 · DOI · Paper page
- Gijsbers, 2010, LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin, Mol. Ther., 18, 552, 10.1038/mt.2010.36 · DOI · Paper page
- De Rijck, 2010, High-resolution profiling of the LEDGF/p75 chromatin interaction in the ENCODE region, Nucleic Acids Res., 38, 6135, 10.1093/nar/gkq410 · DOI · Paper page
- Pandey, 2007, Transcriptional coactivator LEDGF/p75 modulates human immunodeficiency virus type 1 integrase-mediated concerted integration, J. Virol., 81, 3969, 10.1128/JVI.02322-06 · DOI · Paper page
- McKee, 2008, Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein, J. Biol. Chem., 283, 31802, 10.1074/jbc.M805843200 · DOI · Paper page
- Vanegas, 2005, Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering, J. Cell Sci., 118, 1733, 10.1242/jcs.02299 · DOI · Paper page
- Vandegraaff, 2006, Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication, Virology, 346, 415, 10.1016/j.virol.2005.11.022 · DOI · Paper page
- Wang, 2012, HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor, Nucleic Acids Res., 40, 11518, 10.1093/nar/gks913 · DOI · Paper page
- Schrijvers, 2012, HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells, Retrovirology, 9, 84, 10.1186/1742-4690-9-84 · DOI · Paper page
- Cattoglio, 2007, Hot spots of retroviral integration in human CD34+ hematopoietic cells, Blood, 110, 1770, 10.1182/blood-2007-01-068759 · DOI · Paper page
- Ambrosi, 2011, Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors, PLoS Comput. Biol., 7, e1002292, 10.1371/journal.pcbi.1002292 · DOI
- Lelek, 2015, Chromatin organization at the nuclear pore favours HIV replication, Nat. Commun., 6, 6483, 10.1038/ncomms7483 · DOI · Paper page
- Di Nunzio, 2013, Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication, Virology, 440, 8, 10.1016/j.virol.2013.02.008 · DOI · Paper page
- Moloney, 1960, Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations, J. Natl. Cancer Inst., 24, 933
- Cavazza, 2013, Mechanisms of retroviral integration and mutagenesis, Hum. Gene Ther., 24, 119, 10.1089/hum.2012.203 · DOI · Paper page
- Felice, 2009, Transcription factor binding sites are genetic determinants of retroviral integration in the human genome, PLoS ONE, 4, e4571, 10.1371/journal.pone.0004571 · DOI · Paper page
- Biasco, 2011, Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell, EMBO Mol. Med., 3, 89, 10.1002/emmm.201000108 · DOI · Paper page
- Cavazza, 2016, Dynamic transcriptional and epigenetic regulation of human epidermal keratinocyte differentiation, Stem Cell Reports, 6, 618, 10.1016/j.stemcr.2016.03.003 · DOI
- Romano, 2016, Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment, Sci. Rep., 6, 24724, 10.1038/srep24724 · DOI
- Aiuti, 2007, Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy, J. Clin. Invest., 117, 2233, 10.1172/JCI31666 · DOI · Paper page
- Deichmann, 2011, Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy, Mol. Ther., 19, 2031, 10.1038/mt.2011.178 · DOI · Paper page
- Lin, 2003, The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes, J. Virol., 77, 5030, 10.1128/JVI.77.8.5030-5036.2003 · DOI · Paper page
- Lee, 1994, Protection of retroviral DNA from autointegration: involvement of a cellular factor, Proc. Natl. Acad. Sci. USA, 91, 9823, 10.1073/pnas.91.21.9823 · DOI · Paper page
- Studamire, 2008, Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors, Retrovirology, 5, 48, 10.1186/1742-4690-5-48 · DOI · Paper page
- Delmore, 2011, BET bromodomain inhibition as a therapeutic strategy to target c-Myc, Cell, 146, 904, 10.1016/j.cell.2011.08.017 · DOI · Paper page
- Belkina, 2012, BET domain co-regulators in obesity, inflammation and cancer, Nat. Rev. Cancer, 12, 465, 10.1038/nrc3256 · DOI · Paper page
- Umehara, 2010, Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain, J. Biol. Chem., 285, 7610, 10.1074/jbc.M109.062422 · DOI
- Hu, 2008, Reduced genotoxicity of avian sarcoma leukosis virus vectors in rhesus long-term repopulating cells compared to standard murine retrovirus vectors, Mol. Ther., 16, 1617, 10.1038/mt.2008.135 · DOI · Paper page
- Moiani, 2014, Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells, Genes (Basel), 5, 415, 10.3390/genes5020415 · DOI
- Suerth, 2014, Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy, Viruses, 6, 4811, 10.3390/v6124811 · DOI
- Faschinger, 2008, Mouse mammary tumor virus integration site selection in human and mouse genomes, J. Virol., 82, 1360, 10.1128/JVI.02098-07 · DOI · Paper page
- Konstantoulas, 2014, Mouse mammary tumor virus-based vector transduces non-dividing cells, enters the nucleus via a TNPO3-independent pathway and integrates in a less biased fashion than other retroviruses, Retrovirology, 11, 34, 10.1186/1742-4690-11-34 · DOI · Paper page
- Gillet, 2011, The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones, Blood, 117, 3113, 10.1182/blood-2010-10-312926 · DOI · Paper page
- Heneine, 1998, Identification of a human population infected with simian foamy viruses, Nat. Med., 4, 403, 10.1038/nm0498-403 · DOI · Paper page
- Olszko, 2013, Foamy virus vectors for HIV gene therapy, Viruses, 5, 2585, 10.3390/v5102585 · DOI
- Trobridge, 2006, Foamy virus vector integration sites in normal human cells, Proc. Natl. Acad. Sci. USA, 103, 1498, 10.1073/pnas.0510046103 · DOI · Paper page
- Nowrouzi, 2006, Genome-wide mapping of foamy virus vector integrations into a human cell line, J. Gen. Virol., 87, 1339, 10.1099/vir.0.81554-0 · DOI · Paper page
- Nasimuzzaman, 2014, High-titer foamy virus vector transduction and integration sites of human CD34(+) cell-derived SCID-repopulating cells, Mol. Ther. Methods Clin. Dev., 1, 14020, 10.1038/mtm.2014.20 · DOI
- Olszko, 2015, Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection, Gene Ther., 22, 591, 10.1038/gt.2015.20 · DOI
- Hocum, 2016, Retargeted foamy virus vectors integrate less frequently near proto-oncogenes, Sci. Rep., 6, 36610, 10.1038/srep36610 · DOI
- Maruggi, 2009, Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design, Mol. Ther., 17, 851, 10.1038/mt.2009.51 · DOI · Paper page
Cited by
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Gong, Y., Klein Wolterink, R. G. J., Wang, J., Bos, G. M. J., & Germeraad, W. T. V. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01083-5 · Cited by 379
Gene therapy using haematopoietic stem and progenitor cells
Ferrari, G., Thrasher, A. J., & Aiuti, A. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00298-5 · Cited by 254
Viral Vectors for Gene Transfer
Chen, Y. H., Keiser, M. S., & Davidson, B. L. (2018) · Current Protocols in Mouse Biology · doi:10.1002/cpmo.58 · Cited by 146
Picht, S., Farrera-Sal, M., Hiller, A. L., Brumhard, S., Klaas, A. M., Schulenberg, S., Friedrich, R., Scholz, C., Hemmerling, L., Simon, D. N., et al. (2026) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2026.102929 · Cited by 7
Metadata
- Authors
- Poletti, V., & Mavilio, F.
- Venue
- Molecular Therapy - Methods & Clinical Development
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 8
- Pages
- 31-41
- ISSN
- 2329-0501
- Cited by
- 76
- References
- 43
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.